Ayesha Curry and Michael Mina’s International Smoke in SoMa has closed. The Mina Group says the space will be renovated and a Neighborhood Test Kitchen is planned.

Waymo is opening its Zeekr‑built Ojai robotaxi to select riders in San Francisco, Los Angeles and Phoenix as it pushes to scale driverless trips.

A woman was shot near Prescott Elementary in West Oakland on Thursday morning and was hospitalized in stable condition. Police say the investigation is ongoing.

Two Palo Alto tenants say their landlord gave free or discounted units to Ukrainian refugees while charging others more; the suit seeks about $106,000 and heads to a June 1 hearing.

California sued 23andMe, alleging the company downplayed a 2023 hack that exposed nearly 7 million customers’ genetic data and broke state privacy laws.

MidPen proposes a seven-story, 95-unit, 100% affordable project on county-owned land at 626 Walnut St in San Carlos, prioritizing local employees and low-income households.

A 17-year-old was arrested in San Mateo after police say he caused multiple hit-and-runs while intoxicated; a passenger suffered minor injuries and was released to a parent. The case is under investigation.

Masked federal officers detained a man on a Glen Park street Wednesday morning. Witnesses and video show a short, armed operation that left neighbors rattled.

A hidden Woodside compound reborn as a French‑style retreat is listed at $14.9M, complete with a 3,000‑bottle cellar, clay tennis court and guest cottages.

A jury convicted 84-year-old Alan Frank Russell on 12 felony counts of child molestation and a possession charge. Sentencing is scheduled for June 22, 2026.

Velocity Invitational returns to Sonoma Raceway May 29–31 with F1 guests, a Porsche Sprint Challenge appearance, ride‑alongs and an on‑site Cars & Bids auction. Expect paddock access, VIP packages and family bundles.

A 19‑year study of more than 20,000 people found reading, puzzles or desk work while seated was linked with a modestly lower dementia risk compared with watching TV. The results suggest small swaps — an hour of TV for a book — could add up over decades.

Gilead’s Hepcludex won FDA accelerated approval on May 22, 2026 — the first U.S. therapy for chronic hepatitis D — as Mirum and Vir push rival candidates toward late‑stage results.